Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221717 | 0.97 | APLNR (0.41) | APLNRFFAR3CYP2C19 | |
| Hydrochloric Acid SCHEMBL8617904 | 0.93 | APLNR (0.39) | APLNRFFAR3CYP2C19 | |
| SCHEMBL14707135 | 0.77 | APLNR (0.33) | APLNR | |
| SCHEMBL4888774 | 0.76 | APLNR (0.41) | APLNRFFAR3CYP2C19 | |
| SCHEMBL5458745 | 0.75 | APLNR (0.36) | APLNR | |
| SCHEMBL11321430 | 0.73 | APLNR (0.35) | APLNRFFAR3CYP2C19 | |
| SCHEMBL29200814 | 0.73 | MAPK1 (0.41) | APLNRFFAR3CYP2C19 | |
| SCHEMBL2880099 | 0.71 | APLNR (0.33) | APLNRFFAR3CYP2C19 | |
| SCHEMBL11131650 | 0.71 | APLNR (0.33) | APLNRFFAR3CYP2C19 | |
| SCHEMBL284401 | 0.71 | APLNR (0.38) | APLNRFFAR3CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8518979-B2 | Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-08-27 | — | — | US | disclosed |
| US-20100152254-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2010-06-17 | — | — | US | disclosed |
| EP-2114864-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008102348-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2008-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152254-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | INA, GBA1, SCN1A | APLNR 3475/4885FFAR3 3407/4885CYP2C19 2329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.